211 related articles for article (PubMed ID: 20960197)
41. Von Hippel-Lindau disease with multiple malignant renal tumors: the importance of genetic testing.
Shah DR; Hoeksema J; Korbet SM
Clin Nephrol; 2000 Mar; 53(3):216-21. PubMed ID: 10749302
[TBL] [Abstract][Full Text] [Related]
42. Hereditary renal cancers.
Choyke PL; Glenn GM; Walther MM; Zbar B; Linehan WM
Radiology; 2003 Jan; 226(1):33-46. PubMed ID: 12511666
[TBL] [Abstract][Full Text] [Related]
43. Imaging findings of hereditary renal tumors, a review of what the radiologist should know.
Czarniecki M; Gautam R; Choyke PL; Turkbey B
Eur J Radiol; 2018 Apr; 101():8-16. PubMed ID: 29571805
[TBL] [Abstract][Full Text] [Related]
44. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
45. Inherited forms of renal cell carcinoma.
Kiuru M; Kujala M; Aittomäki K
Scand J Surg; 2004; 93(2):103-11. PubMed ID: 15285561
[TBL] [Abstract][Full Text] [Related]
46. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
47. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
48. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
[TBL] [Abstract][Full Text] [Related]
49. Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report.
Garg K; Tickoo SK; Soslow RA; Reuter VE
Am J Surg Pathol; 2011 Aug; 35(8):1235-7. PubMed ID: 21753700
[TBL] [Abstract][Full Text] [Related]
50. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
[TBL] [Abstract][Full Text] [Related]
51. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.
Pfaffenroth EC; Linehan WM
Expert Opin Biol Ther; 2008 Jun; 8(6):779-90. PubMed ID: 18476789
[TBL] [Abstract][Full Text] [Related]
52. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
[TBL] [Abstract][Full Text] [Related]
53. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis.
Alchoueiry M; Cornejo K; Henske EP
Semin Diagn Pathol; 2024 Jan; 41(1):1-7. PubMed ID: 38008653
[TBL] [Abstract][Full Text] [Related]
54. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
55. Familial adult renal neoplasia.
Takahashi M; Kahnoski R; Gross D; Nicol D; Teh BT
J Med Genet; 2002 Jan; 39(1):1-5. PubMed ID: 11826016
[TBL] [Abstract][Full Text] [Related]
56. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
[TBL] [Abstract][Full Text] [Related]
57. Hereditary Renal Cell Carcinoma Syndromes.
Carlo MI
Hematol Oncol Clin North Am; 2023 Oct; 37(5):841-848. PubMed ID: 37258351
[TBL] [Abstract][Full Text] [Related]
58. Molecular genetics of familial renal cell carcinoma syndromes.
Cohen D; Zhou M
Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
[TBL] [Abstract][Full Text] [Related]
59. Impact of genetics on the diagnosis and treatment of renal cancer.
Singer EA; Bratslavsky G; Middelton L; Srinivasan R; Linehan WM
Curr Urol Rep; 2011 Feb; 12(1):47-55. PubMed ID: 21128028
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.
Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM
J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
